January / February 2019
Features
20 milestones ahead in AMD, DME meds
A look at chemical and biologic agents queued this year or next for key steps toward commercialization.
Current and new steroid therapy in noninfectious uveitis
Corticosteroid therapy is the cornerstone of treatment. Sustained delivery systems and concomitant use with other medications are expanding options.
Know the Hazards that Lurk at 'Cell Therapy' Clinics
Commercial clinics peddle unproven therapies that have harmed patients. Retina specialists have a duty to educate their patients about these hazards.
PRP vs. anti-VEGF for DR patients lost to follow-up
After LTFU, visual acuity worsens in both anti-VEGF and PRP groups, but recovers somewhat in the former.
Departments
Coding Commentary
2019 updates, changes and trends
Some of the coding changes are minor, others not so. Here’s a rundown.
Editor's Page
Imaging Forum
Strange symptoms point to rare disease
Widefield fluorescein angiography helps arrive at diagnosis after suspicious visual changes.
News
Retina Rounds
Maculopathy in the middle
This patient with migraines presents with an unusual cause of acute vision loss.
Social Media Specialist
Why you need an online brand
Crafting your own unique identity is the first step in embracing the potential of social media.
Surgical Pearl Video
A far reach: PPV in highly myopic eyes
Pearls for performing a pars plana vitrectomy in pathologic myopia.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
